Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

McMaster University

$100,000.00

Left Atrial Appendage Occlusion Study III (LAAOS III)

EF 2016-17

Résumé
Atrial fibrillation (AF) is a common heart rhythm disorder and a major cause of stroke, a leading cause of death and disability in Canada. AF can lead to the formation of blood clots in the upper chamber of the heart that can travel to the brain and cause a stroke. We have made progress in preventing strokes due to AF by using blood thinning drugs (anticoagulants) and by developing better anticoagulants. However, blood thinners have some drawbacks: they can cause serious bleeding, doctors sometimes do not prescribe them to patients who should take them, and patients may not take the blood thinners regularly or may stop them completely. We know that almost all blood clots in patients with AF form in a structure attached to the upper chamber of the heart called left atrial appendage. This structure can be easily removed at low cost and at low risk during open-heart surgery that is performed for other purposes such as coronary bypass or valve replacement. We believe that left atrial appendage removal will reduce stroke in patients with AF. The LAAOS III clinical trial randomly (like the flip of a coin) assigns patients with AF having heart surgery for another reason to have their left atrial appendage removed or not removed. These patients will be treated as usual except for this small procedure, which has been shown to be quite safe. We have recruited over 1,600 patients into an early phase of the trial, which tested the design of the current proposal. We now seek funding to continue recruitment to the full 4,700 patients needed to determine if removing the left atrial appendage reduces stroke and other complications in patients who receive usual therapy for AF. A positive study will change the way heart surgery is performed on AF patients and reduce the number of strokes in a large population. It will also promote further research into this approach to stroke prevention that could be applied beyond AF patients undergoing heart surgery.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
351768
Name
Whitlock Richard
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Project Grant Competition
Projecttitle
Left Atrial Appendage Occlusion Study III (LAAOS III)
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Atrial Fibrillation; Clinical Trial; Left Atrial Appendage Occlusion; Stroke
Abstract
Atrial fibrillation (AF) is a common heart rhythm disorder and a major cause of stroke, a leading cause of death and disability in Canada. AF can lead to the formation of blood clots in the upper chamber of the heart that can travel to the brain and cause a stroke. We have made progress in preventing strokes due to AF by using blood thinning drugs (anticoagulants) and by developing better anticoagulants. However, blood thinners have some drawbacks: they can cause serious bleeding, doctors sometimes do not prescribe them to patients who should take them, and patients may not take the blood thinners regularly or may stop them completely. We know that almost all blood clots in patients with AF form in a structure attached to the upper chamber of the heart called left atrial appendage. This structure can be easily removed at low cost and at low risk during open-heart surgery that is performed for other purposes such as coronary bypass or valve replacement. We believe that left atrial appendage removal will reduce stroke in patients with AF. The LAAOS III clinical trial randomly (like the flip of a coin) assigns patients with AF having heart surgery for another reason to have their left atrial appendage removed or not removed. These patients will be treated as usual except for this small procedure, which has been shown to be quite safe. We have recruited over 1,600 patients into an early phase of the trial, which tested the design of the current proposal. We now seek funding to continue recruitment to the full 4,700 patients needed to determine if removing the left atrial appendage reduces stroke and other complications in patients who receive usual therapy for AF. A positive study will change the way heart surgery is performed on AF patients and reduce the number of strokes in a large population. It will also promote further research into this approach to stroke prevention that could be applied beyond AF patients undergoing heart surgery.
Competitiondate
201604
Approvedterm2
1 yr 0 mth
Pinamesdelim
Whitlock, Richard
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~